EMINAT Trademark Application Published for Opposition

The USPTO has published the trademark application for EMINAT (TM99715867) for opposition. The application, filed on March 20, 2026, and published on March 21, 2026, seeks to register the mark for a broad array of medical and scientific services. These include the collection and preservation of human blood, medical information provision, diagnostic and treatment testing, clinic services, blood testing for diagnostic and treatment purposes, medical evaluation for rehabilitation, wellness programs, scientific research, clinical trials, and laboratory research services related to pharmaceuticals, genetics, and biotechnology.

This publication initiates a period during which any party believing they would be harmed by the registration of this mark can file an opposition. Companies operating in the pharmaceutical, biotechnology, and healthcare sectors, particularly those involved in clinical trials or advanced medical research, should be aware of this publication. While this is a trademark matter and not a direct regulatory change, it signifies a potential new market entrant or brand presence in areas related to medical services and research, which may warrant monitoring by competitors or collaborators.